K920662 is an FDA 510(k) clearance for the VASCOTWIST 9/60. Classified as Permanent Pacemaker Electrode (product code DTB), Class III - Premarket Approval.
Submitted by Vascor Medical Corp. (Tarpon Springs, US). The FDA issued a Cleared decision on November 24, 1993 after a review of 649 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3680 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. High regulatory complexity profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.
View all Vascor Medical Corp. devices